6-K: 9M and Q3 2024 Results
6-K: AstraZeneca Invests $3.5 Billion in US
6-K: H1 and Q2 2024 Results
AstraZeneca | 6-K: AstraZeneca to Deliver $80bn Revenue by 2030
6-K: Q1 2024 Results
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 20-F: FY2023 Annual Report
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA PLC | 20-F: FY2022 Annual Report
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 20-F: FY2021 Annual Report